Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKNT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,754
Award facts
- Contract value 100% obligated
- $30,753.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,753.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen medication on January 21, 2026, with an ultimate completion date of January 22, 2026. The contract is unclassified as a set-aside and represents a direct procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award, with its parent company Cencora, Inc. (doing business as AmerisourceBergen) serving as the ultimate organization. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical commodities to military healthcare programs globally.
This procurement exemplifies the critical role AmerisourceBergen maintains within the Defense Logistics Agency's pharmaceutical supply chain. Mounjaro is a diabetes medication utilized across military treatment facilities and veteran healthcare programs. The award demonstrates the company's consistent capability to fulfill competitive federal medical procurement requirements through firm fixed-price delivery orders across a diverse portfolio of therapeutic domains. AmerisourceBergen's IDC with DLA Troop Support Medical enables flexible ordering of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities, with this specific delivery order representing one task under that expansive umbrella contract designed to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FAKNT?
SPE2DR26FAKNT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FAKNT worth?
The government has obligated $30,754 on SPE2DR26FAKNT.
Is contract SPE2DR26FAKNT an order under another contract?
Yes. SPE2DR26FAKNT is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKNT competed?
The extent of competition for SPE2DR26FAKNT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award